Plan to axe drug price fixing21st April 2008
The government's intention to get rid of the Pharmaceutical Price Regulation Scheme (PPRS) would dramatically affect the healthcare communications industry, according to a prominent PR consultant.
Fleishman-Hillard director Claire Ashbridge-Thomlinson spoke at her agency's yearly healthcare industry debate. Ashbridge-Thomlinson said: 'Fixed pricing will have implications for marketing spend and a huge impact on the PR and PA side. If pharma companies receive less money for their drugs in the UK, they will have less to spend on comms activity. PR and PA agencies need to be aware of this."
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: Plan to axe drug price fixing
Author: Jess Laurence
Article Id: 6438
Date Added: 21st Apr 2008